Related Experiment Videos
Arginine vasopressin 4-9 retards spatial alternation learning
W F McDaniel1, P E Waters, E J Davall
1Department of Psychology, Georgia College, Milledgeville 31061.
Neuropeptides
|November 1, 1989
Summary
Arginine vasopressin (AVP) 4-9 administration impaired rats' ability to learn a spatial alternation task. This vasopressin metabolite interfered with cognitive learning acquisition during T-maze training.
Area of Science:
- Neuroscience
- Cognitive Science
- Pharmacology
Background:
- Arginine vasopressin (AVP) plays a role in social behavior and memory.
- The metabolite AVP 4-9 is centrally active and may influence cognitive functions.
Purpose of the Study:
- To investigate the effect of AVP 4-9 on the acquisition of a spatial learning task in rats.
- To determine if chronic administration of AVP 4-9 during training impacts cognitive performance.
Main Methods:
- Adult male rats with neocortical injuries (parietal, frontal, or sham) were trained on a T-maze spatial alternation task.
- Rats received chronic subcutaneous administration of either 0 or 1.2 micrograms of AVP 4-9 via osmotic mini-pumps.
- Performance was assessed by the number of errors to reach a learning criterion.
Main Results:
- Rats administered AVP 4-9 showed significantly more errors during T-maze training compared to controls.
- This indicates a retardation in the acquisition of the spatial alternation task.
- Neocortical injury type did not significantly alter the effect of AVP 4-9 on learning.
Conclusions:
- Centrally active AVP 4-9 can interfere with the acquisition of cognitive learning tasks.
- These findings suggest a modulatory role of vasopressin metabolites in learning processes.
- Further research is needed to elucidate the precise mechanisms of AVP 4-9 in cognitive function.